DelveInsight

View All

Delveinsight
Anticoagulants Market A Big Boom

Analyze Anticoagulants Market with DelveInsight Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. They can keep harmful clots from forming in heart, veins or arteries. Clots can block blood flow and cause a heart attack or stroke. Until recently, ...

Find More

Delveinsight
Antibody-Drug Conjugate and Big Pharmaceutical Companies

Antibody Drug Conjugate and Big Pharmaceutical Companies Boom Antibody-drug conjugates is gaining popularity in the Biopharmaceutical industries. As Initial trials with these targeted treatments show success, more companies are looking to produce these drugs. Although antibody-drug conjugates show promise in the d...

Find More

Delveinsight
What are your views on Gene Therapy?

"We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our genes, "quotes James Watson. This fate that Watson is talking about is contained in our genes, and deals with a new technique, GENE THERAPY. Gene therapy is an innovative way to fix genetic problem from th...

Find More

Delveinsight
Next Generation Antibody-Drug Conjugate Therapeutics and Market Analysis

Antibody-Drug Conjugates-A Big Boom! Therapeutics developed to create innovative medicines based on the use of new and improved antibodies is the next generation cure for the treatment of various diseases. In past decade, the antibody drug conjugates have emerged out as the active areas of many biopharmaceutical ...

Find More

Delveinsight
DelveInsight Hiring!!!!

Looking for Passionate Candidates Mail your updated Resume to careers@delveinsight.com  www.delveinsight.com Twitter, Facebook, LinkedIn JOB DESCRIPTION Profile Offered: Associate Analyst Education: M. Pharma/M.tech Biotech Roles and Responsibilities: Conduct market research through primary and secondary sou...

Find More

Delveinsight
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy

Antibody–drug conjugates (ADCs), a new weapon of 21st Century for fighting Cancer Traditional cancer chemotherapy was having harsh side effects and also leads to systemic toxicity. The approach was also referred to as the carpet-bombing strategy for fighting cancer. Traditional chemotherapy does not discriminate b...

Find More

Delveinsight
DelveInsight: One Year Anniversary!

Thanks to our great Clients, Partners, Colleagues, Family and Friends, we're celebrating the completion of our first year in business. Thanks for helping to make DelveInsight a success!!

Find More

Delveinsight
DelveInsight’s Gastrointestinal based Gene Therapy Reports

Gene Therapy: The “Promise” to cure Gastrointestinal disorders! About Gastrointestinal disorders Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestions, the liver, gallblad...

Find More

Delveinsight
DelveInsight’s Genetic disorders based Gene Therapy Reports

Gene Therapy to “fix” Genetic disorders! "We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our genes, "quotes James Watson. This fate and our future is locked in our genes, and Gene therapy is unlocking these doors. Many physicians are predicting that in twent...

Find More

Delveinsight
Global Hemophilia Market

Get Market Intelligence of Hemophilia Market with DelveInsight The Haemophilia Market is driven by clotting factor concentrates. Besides hemophilia A and B, and those with von Willebrand disease (VWD), is also sometimes treated with clotting factor. Currently about 20,000 people have hemophilia in the US; about ...

Find More